Increasing Health Adversaries Associated with JAK Inhibitors in Rheumatoid Arthritis to Raise Concern for the Future
Rheumatoid arthritis is a chronic disease and a long-term auto-immune disorder that primary affects the joints. Janus kinase (JAK) inhibitors are a type of medication, which function by inhibiting the activity of Janus kinase which is a family of enzymes being one or more in number. They are being used in the treatment of rheumatoid arthritis and are said to contribute to the therapeutic landscape meaningfully. Small-molecule JAK inhibitors are proposed to provide a significant alternative to biological therapies for...
View full press release